Literature DB >> 18723274

A new TAG-72 cancer marker peptide identified by phage display.

Ling Chen1, Yi Wang, Xinrong Liu, Shuping Dou, Guozheng Liu, Donald J Hnatowich, Mary Rusckowski.   

Abstract

Radiolabeled peptides as markers of cancer targets have demonstrated their value in diagnostic imaging and radiotherapy. The 16 mer f88-4/Cys6 phage display library was applied to affinity purified TAG-72 and three consensus peptides were identified: VHHSCTKLTHCCQNWH (A2-13), GGVSCMQTSPVCENNL (A2-6) and TKRDCSAQNYGCQKAI (A2-11). The A2-13 and A2-6 phages showed the highest percent binding to LS-174T cells by flow cytometry and were 3-fold higher than a control phage, while fluorescence microscopy showed that both A2-6 and A2-13 phages bound to the LS-174T cell membrane. However, only the A2-6 phage demonstrated specificity by low binding to the TAG-72 negative cell HT-29. Furthermore, the synthesized free A2-6 peptide demonstrated specific binding to LS-174T cells by flow cytometry and by immunohistochemical staining of xenograft tumor compared to normal colon. These data indicate that the A2-6 peptide is specific for the TAG-72 cancer target.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18723274      PMCID: PMC2680929          DOI: 10.1016/j.canlet.2008.07.009

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  22 in total

1.  Yttrium-90-labelled somatostatin-analogue for cancer treatment.

Authors:  A Otte; J Mueller-Brand; S Dellas; E U Nitzsche; R Herrmann; H R Maecke
Journal:  Lancet       Date:  1998-02-07       Impact factor: 79.321

2.  Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study.

Authors:  C Van de Wiele; F Dumont; R Vanden Broecke; W Oosterlinck; V Cocquyt; R Serreyn; S Peers; J Thornback; G Slegers; R A Dierckx
Journal:  Eur J Nucl Med       Date:  2000-11

3.  In vivo evaluation of a lead-labeled monoclonal antibody using the DOTA ligand.

Authors:  D E Milenic; M Roselli; M W Brechbiel; C G Pippin; T J McMurray; J A Carrasquillo; D Colcher; R Lambrecht; O A Gansow; J Schlom
Journal:  Eur J Nucl Med       Date:  1998-05

4.  Organ targeting in vivo using phage display peptide libraries.

Authors:  R Pasqualini; E Ruoslahti
Journal:  Nature       Date:  1996-03-28       Impact factor: 49.962

5.  Labeling peptides with technetium-99m using a bifunctional chelator of a N-hydroxysuccinimide ester of mercaptoacetyltriglycine.

Authors:  D J Hnatowich; T Qu; F Chang; A C Ley; R C Ladner; M Rusckowski
Journal:  J Nucl Med       Date:  1998-01       Impact factor: 10.057

6.  Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model.

Authors:  W Arap; R Pasqualini; E Ruoslahti
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

7.  Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study.

Authors:  Berthold A Nock; Anastasia Nikolopoulou; Athanassios Galanis; Paul Cordopatis; Beatrice Waser; Jean-Claude Reubi; Theodosia Maina
Journal:  J Med Chem       Date:  2005-01-13       Impact factor: 7.446

8.  Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.

Authors:  R Markwalder; J C Reubi
Journal:  Cancer Res       Date:  1999-03-01       Impact factor: 12.701

9.  Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin.

Authors:  E P Krenning; W H Bakker; W A Breeman; J W Koper; P P Kooij; L Ausema; J S Lameris; J C Reubi; S W Lamberts
Journal:  Lancet       Date:  1989-02-04       Impact factor: 79.321

10.  Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3.

Authors:  A Thor; N Ohuchi; C A Szpak; W W Johnston; J Schlom
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

View more
  14 in total

Review 1.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

2.  Tumor associated glycoprotein-72 is a novel marker for poor survival in hepatocellular carcinoma.

Authors:  Yang Zhang; Zhan-sheng Deng; Ming-mei Liao; Ning Wang; Xiao-qing Zhang; Hai-yang Yu; Yang-de Zhang
Journal:  Pathol Oncol Res       Date:  2012-03-21       Impact factor: 3.201

3.  Functional recognition of the modified human tRNALys3(UUU) anticodon domain by HIV's nucleocapsid protein and a peptide mimic.

Authors:  William D Graham; Lise Barley-Maloney; Caren J Stark; Amarpreet Kaur; Christina Stolarchuk; Khrystyna Stolyarchuk; Brian Sproat; Grazyna Leszczynska; Andrzej Malkiewicz; Nedal Safwat; Piotr Mucha; Richard Guenther; Paul F Agris
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

4.  In vitro gastric cancer cell imaging using near-infrared quantum dot-conjugated CC49.

Authors:  Yun-Peng Zhang; Peng Sun; Xu-Rui Zhang; Wu-Li Yang
Journal:  Oncol Lett       Date:  2012-08-20       Impact factor: 2.967

5.  Identification of a high affinity TAG-72 binding peptide by phage display selection.

Authors:  Nan Xiao; Dengfeng Cheng; Yi Wang; Ling Chen; Xinrong Liu; Shuping Dou; Guozheng Liu; Minmin Liang; Donald J Hnatowich; Mary Rusckowski
Journal:  Cancer Biol Ther       Date:  2011-01-01       Impact factor: 4.742

6.  A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio.

Authors:  Ming-Hsien Chien; Wei-Min Chang; Wei-Jiunn Lee; Yu-Chan Chang; Tsung-Ching Lai; Derek V Chan; Rahul Sharma; Yuan-Feng Lin; Michael Hsiao
Journal:  Mol Cancer Ther       Date:  2017-03-14       Impact factor: 6.261

7.  Comparing two TAG-72 binding peptides previously identified by phage display as potential imaging agents.

Authors:  Ling Chen; Yi Wang; Dengfeng Cheng; Shuping Dou; Xinrong Liu; Guozheng Liu; Donald J Hnatowich; Mary Rusckowski
Journal:  Nucl Med Commun       Date:  2011-10       Impact factor: 1.690

8.  A preliminary study on the expression of tumor-associated glycoprotein-72 in human gliomas.

Authors:  Dongchun Wang; Yan Zhang; Xiaoli Li; Jianzhong Cui; Shuo Wang
Journal:  Med Oncol       Date:  2011-07-23       Impact factor: 3.064

9.  Comparison between two labeled agents in mice using a coinjection-ratio approach in contrast to a conventional group approach.

Authors:  Shuping Dou; Yuzhen Wang; Bruce Barton; Ling Chen; Mary Rusckowski; Leonard D Shultz; Dale L Greiner; Guozheng Liu
Journal:  Nucl Med Biol       Date:  2013-10-09       Impact factor: 2.408

Review 10.  Tumor-targeting peptides from combinatorial libraries.

Authors:  Ruiwu Liu; Xiaocen Li; Wenwu Xiao; Kit S Lam
Journal:  Adv Drug Deliv Rev       Date:  2016-05-19       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.